Tonix promotes Siobhan Fogarty to Chief Technical Officer; PDUFA date Aug 15, 2025

Tonix Pharmaceuticals Holding Corp.

Siobhan Fogarty appointed CTO effective February 3, 2025; annual salary of €385,000.
Fogarty previously served as EVP Product Development since February 2021 and joined Tonix in 2016.
FDA PDUFA goal date for TNX-102 SL (fibromyalgia) remains August 15, 2025; NDA submitted.
Company preparing for potential launch of TNX-102 SL for management of fibromyalgia.

item 5.02 item 7.01 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Siobhan Fogarty

Chief Technology Officer

TNXP · Tonix Pharmaceuticals Holding Corp.

Effective: 2025-02-03
Filed: February 4, 2025, 6:59 PM ET

appointed Siobhan Fogarty as the Company’s Chief Technology Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Siobhan Fogarty was appointed as Chief Technology Officer at Tonix Pharmaceuticals Holding Corp..

Action: appointed
Role: Chief Technology Officer

Exact text from the filing

appointed Siobhan Fogarty as the Company’s Chief Technology Officer

View on SEC.gov

Tonix Pharmaceuticals Holding Corp. filing history →

Source: SEC EDGAR

accession 0001999371-25-001136

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.